EV/EBITDA
-26.45
+0.44+1.64%
117 min ago
Summary
- As of February 8, 2025, PLX EV/EBITDA is -26.45, with a rise of +0.44 (+1.64%) during the most recent trading day.
- Over the past year, PLX EV/EBITDA has dropped by -35.00 (-409.36%).
- PLX EV/EBITDA is now -120.75% below its all-time high of 127.48.
Performance
PLX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
PLX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +1.6% | -1.6% | -1.4% |
| 1 m1 month | -20.8% | +20.8% | +18.1% |
| 3 m3 months | -162.9% | +162.9% | +122.1% |
| 6 m6 months | -312.6% | +124.5% | +162.1% |
| ytdytd | -46.8% | +46.8% | +39.4% |
| 1 y1 year | -409.4% | +54.9% | +77.1% |
| 5 y5 years | -142.7% | +80.7% | -24.7% |
PLX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -25.3% | -26.89 | +1.6% | |
| 3 m | 3-month | -10.06 | -162.9% | -26.89 | +1.6% |
| 6 m | 6-month | -5.86 | -351.4% | -26.89 | +1.6% |
| 1 y | 1-year | 9.73 | -371.8% | -26.89 | +1.6% |
| 3 y | 3-year | 10.80 | -344.9% | -26.89 | +1.6% |
| 5 y | 5-year | 127.48 | -120.8% | -83.92 | +68.5% |
| alltime | all time | 127.48 | -120.8% | -489.09 | +94.6% |
Protalix BioTherapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -26.45(+46.8%) |
| 2024 | -18.02(-266.9%) |
| 2023 | 10.80(-229.3%) |
| 2022 | -8.35(+385.5%) |
| 2021 | -1.72(-104.4%) |
| 2020 | 38.73(-466.8%) |
| 2019 | -10.56(+222.0%) |
| 2018 | -3.28(+144.8%) |
| 2017 | -1.34(-53.1%) |
| 2016 | -2.86(-38.0%) |
| 2015 | -4.61(-37.4%) |
| 2014 | -7.37(-35.5%) |
| 2013 | -11.43(-79.2%) |
| Date | Value |
|---|---|
| 2012 | -54.89(+282.2%) |
| 2011 | -14.36(-51.0%) |
| 2010 | -29.31(+93.6%) |
| 2009 | -15.14(+256.2%) |
| 2008 | -4.25(-25.3%) |
| 2007 | -5.69(-93.9%) |
| 2006 | -93.19(+2593.4%) |
| 2005 | -3.46(>+9900.0%) |
| 2004 | -0.01(-99.9%) |
| 2003 | -6.70(-328.7%) |
| 2002 | 2.93(+365.1%) |
| 2001 | 0.63(-169.2%) |
| 2000 | -0.91(-82.1%) |
| 1999 | -5.09 |
FAQ
- What is Protalix BioTherapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Protalix BioTherapeutics?
- What is PLX EV/EBITDA year-to-date change?
- What is Protalix BioTherapeutics EV/EBITDA year-on-year change?
What is Protalix BioTherapeutics EV/EBITDA?
The current EV/EBITDA of PLX is -26.45
What is the all time high EV/EBITDA for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high EV/EBITDA is 127.48
What is PLX EV/EBITDA year-to-date change?
Protalix BioTherapeutics EV/EBITDA has changed by -8.43 (-46.78%) since the beginning of the year
What is Protalix BioTherapeutics EV/EBITDA year-on-year change?
Over the past year, PLX EV/EBITDA has changed by -35.00 (-409.36%)